The Educational Needs of Clinicians Regarding Anticoagulation Therapy for Prevention of Thromboembolism and Stroke in Patients With Atrial Fibrillation

American Journal of Medical Quality

Volumn 31, Issue 1, 2016, Pages 38-46

  Glauser, Terry Ann ^a   Barnes, Justin ^a   Nevins, Holder ^a   Cerenzia, Wendy ^a  

^a CE Outcomes LLC   (United States)

Author keywords

anticoagulation therapy; atrial fibrillation; physician education; practice gaps; stroke; thromboembolism; warfarin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

ADULT; ATRIAL FIBRILLATION; CARDIOLOGY; CLINICAL PRACTICE; COMPLICATION; EDUCATION; FEMALE; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STROKE; THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; ATRIAL FIBRILLATION; ATTITUDE OF HEALTH PERSONNEL; CARDIOLOGY; FEMALE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PHYSICIANS, PRIMARY CARE; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOEMBOLISM;

EID: 84953439282     PISSN: 10628606     EISSN: 1555824X     Source Type: Journal    
DOI: 10.1177/1062860614547363     Document Type: Article

References (31)

1. V.FusterL.E.RydenD.S.Cannom. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011;123:e269-e367.
2. G.V.NaccarelliH.VarkerJ.LinK.L.Schulman. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009;104:1534-1539.
3. Y.MiyasakaM.E.BarnesB.J.Gersh. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119-125.
4. B.F.GageA.D.WatermanW.ShannonM.BoechlerM.W.RichM.J.Radford. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864-2870.
5. A.J.CammP.KirchhofG.Y.Lip. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369-2429.
6. G.Y.LipL.FrisonJ.HalperinD.Lane. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke. 2010;4:2731-2738.
7. R.PistersD.A.LaneR.NieuwlaatC.B.de VosH.J.CrijnsG.Y.Lip. A novel user friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey. Chest. 2010;138:1093-1100.
8. J.W.PeabodyJ.LuckP.GlassmanT.R.DresselhausM.Lee. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA. 2000;283:1715-1722.
9. J.W.PeabodyJ.LuckP.Glassman. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med. 2004;141:771-780.
10. J.VeloskiS.TaiA.S.EvansD.B.Nash. Clinical vignette-based surveys: a tool for assessing physician practice variation. Am J Med Qual. 2005;20:151-157.
11. M.LeviF.D.HobbsA.K.Jacobson. Improving antithrombotic management in patients with atrial fibrillation: current status and perspectives. Semin Thromb Hemost. 2009;35:527-542.
12. JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version. Circ J. 2010;74:2479-2500.
13. L.B.GoldsteinC.D.BushnellR.J.Adams. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517-584.
14. 2 clinical predictor rule to predict ischaemic stroke: a systematic review and meta-analysis. Thromb Haemost. 2011;106:528-538.
15. D.E.SingerG.W.AlbersJ.E.Dalen. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6, suppl):546S-592S.
16. B.E.PusserS.L.RobertsonM.D.RobinsonC.BartonL.A.Dobson. Stroke prevention in atrial fibrillation: are we following the guidelines?N C Med J. 2005;66:9-13.
17. M.G.GeorgeX.TongH.McGruder. Paul Coverdell National Acute Stroke Registry Surveillance: four states, 2005-2007. MMWR Surveill Summ. 2009;58(7):1-23.
18. G.ArepallyK.A.BauerD.L.Bhatt. The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: a survey of current knowledge and practice supporting the need for clinical education. Crit Pathw Cardiol. 2010;9:41-48.
19. N.L.GlazerS.DublinN.L.Smith. Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Arch Intern Med. 2007;167:246-252.
20. L.E.SkolarusL.B.MorgensternJ.B.FroehlichL.D.LisabethD.L.Brown. Guideline-discordant periprocedural interruptions in warfarin therapy. Circ Cardiovasc Qual Outcomes. 2011;4:206-210.
21. A.RussolilloM.N.Di MinnoA.TufanoD.PriscoG.Di Minno. Filling the gap between science & clinical practice: prevention of stroke recurrence. Thromb Res. 2012;129:3-8.
22. Y.L.WangD.WuM.N.Nguyen-Huynh. Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: a consecutive cross-sectional survey. Clin Exp Pharmacol Physiol. 2010;37:775-781.
23. D.McBrideB.BruggenjurgenS.RollS.N.Willich. Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice. J Thromb Thrombolysis. 2007;24:65-72.
24. V.F.TapsonT.M.HyersA.L.Waldo. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med. 2005;165:1458-1464.
25. H.AtarashiH.InoueK.Okumura. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J. 2011;75:1328-1333.
26. L.GorinL.FauchierE.NoninB.CharbonnierD.BabutyG.Y.Lip. Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project. Chest. 2011;140:911-917.
27. S.BoS.ValpredaL.Scaglione. Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after study. BMC Public Health. 2007;7:203.
28. D.L.MurdochK.O’NeillJ.Jackson. Are atrial fibrillation guidelines altering management? A community based study. Scott Med J. 2005;50:166-169.
29. J.WrightJ.BibbyJ.Eastham. Multifaceted implementation of stroke prevention guidelines in primary care: cluster-randomised evaluation of clinical and cost effectiveness. Qual Saf Health Care. 2007;16:51-59.
30. G.M.RuttenJ.HartingS.T.RuttenG.E.BekkeringS.P.Kremers. Measuring physiotherapists’ guideline adherence by means of clinical vignettes: a validation study. J Eval Clin Pract. 2006;12:491-500.
31. C.T.JanuaryL.S.WannJ.S.Alpert. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society [published online March 26, 2014]. J Am Coll Cardiol. doi:10.1016/j.jacc.2014.03.022.